Monday's notice

Next 15 Group (LSE:NFG) told the market on Monday 16 November 2026 that it had applied for 176,336 new ordinary shares of 2.5p to be admitted to AIM. The shares are being issued as consideration linked to the vesting of long-term incentives relating to M. Booth & Associates, the US communications agency within the group. Admission was expected by today, 17 November, after which the company will have 102,504,374 shares in issue. It stated that no shares are held in treasury.

The notice did not give a value for the shares or say how many further awards remain outstanding under the M Booth arrangements.

Why a small issue is worth noting

The timing is notable because the group (LSE:NFG) began a share buyback of up to £5m on 11 November, funded from the £70.4m cash sale of Marker Collective. That programme, run independently by its broker, can buy up to 10,102,894 shares and must end by 31 January 2027. Repurchased shares are to be held in treasury.

The broader point is that acquisition-related share awards still feed into the share base. In the six months to 31 July 2026, the weighted average number of shares was 101.1m, while the diluted figure was 107.1m. The gap included about 3.95m potential shares under so-called growth deals, 1.57m under incentive plans and options, and 0.47m other potentially issuable shares. The company (LSE:NFG) said the rise in dilutive shares contributed to a 3.3% fall in adjusted diluted earnings per share, to 20.7p.

M Booth's place in the group

M Booth and M Booth Health sit within Track 1, the businesses management intends to keep and invest in. Track 1 grew like-for-like Revenue by 1.8% to £143.1m in the first half, with operating profit up 3.5% to £26.3m and a Margin of 18.4%. The company highlighted solid new Business at both M Booth units, including Google for Education, and said M Booth Health was a principal driver of 2.1% organic growth in its continuing US businesses. Marker, sold on 5 November, had produced adjusted operating profit of £9.8m in the year to 31 January 2026, which the continuing group must replace.

Balance sheet context

At 31 July net Debt was £57.3m, or 0.7 times adjusted EBITDA, after £6.2m of acquisition-related cash payments. Contingent consideration on the Balance Sheet totalled £71.5m, of which £67.7m related to Mach49, where the group is contesting the remaining earn-out in arbitration. Following the Marker sale and the buyback, the company put pro forma net cash at about £5.6m at 31 July.

Factors to watch

Share-settled incentives align agency leaders with group performance, but they also mean Buybacks partly offset issuance rather than shrink the share base. The scale of any future vesting is not disclosed in Monday's notice. The Mach49 outcome remains the largest single uncertainty for cash: management expects a ruling within the current financial year, but an adverse result could alter Capital allocation. Statutory results also show a pre-tax loss of £1.5m in the half, largely from litigation and Acquisition accounting costs.

Dates to watch

The Interim Dividend of 4.75p, a cash cost of £4.9m, is payable on 20 November 2026. The buyback runs until the earlier of £5m being spent or 31 January 2027, which is also the financial year end. Management has guided to like-for-like revenue growth for the full year, with revenue and adjusted operating profit in line with market expectations, and said guidance for the continuing group was unchanged after the Marker sale.